{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:29:47Z","timestamp":1788240587278,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100002954","name":"Universit\u00e0 degli Studi di Milano - Bicocca","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002954","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-026-00781-w","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:41:15Z","timestamp":1773823275000},"page":"425-437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lipoprotein(a) Does Not Correlate with Hypertensive Mediated Organ Damage and Subsequent Cardiovascular Events in a Primary Prevention Cohort"],"prefix":"10.1007","volume":"33","author":[{"given":"Chiara","family":"Tognola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide Paolo","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rebora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Cristina Myriam","family":"Intravaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Mancusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Visco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Golia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fucile","family":"Ilaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Merlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Ardissino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Inglese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romano","family":"Danesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Andreano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Rognoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Giannattasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2612-6264","authenticated-orcid":false,"given":"Alessandro","family":"Maloberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"781_CR1","doi-asserted-by":"publisher","unstructured":"Global Cardiovascular Risk Consortium, Magnussen C, Alegre-Diaz J, et al. Global effect of cardiovascular risk factors on lifetime estimates. N Engl J Med. Published online March 30, 2025. https:\/\/doi.org\/10.1056\/NEJMoa2415879","DOI":"10.1056\/NEJMoa2415879"},{"key":"781_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3491764","volume":"2020","author":"MM Jawi","year":"2020","unstructured":"Jawi MM, Frohlich J, Chan SY. Lipoprotein(a) the insurgent: a new insight into the structure, function, metabolism, pathogenicity, and medications affecting lipoprotein(a) molecule. J Lipids. 2020;2020:3491764. https:\/\/doi.org\/10.1155\/2020\/3491764.","journal-title":"J Lipids"},{"issue":"1","key":"781_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010170","volume":"24","author":"A Maloberti","year":"2022","unstructured":"Maloberti A, Fabbri S, Colombo V, et al. Lipoprotein(a): cardiovascular disease, aortic stenosis and new therapeutic option. Int J Mol Sci. 2022;24(1):170. https:\/\/doi.org\/10.3390\/ijms24010170.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"781_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2459\/JCM.0000000000001077","volume":"22","author":"A Cesaro","year":"2021","unstructured":"Cesaro A, Schiavo A, Moscarella E, et al. Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies. J Cardiovasc Med Hagerstown Md. 2021;22(3):151\u201361. https:\/\/doi.org\/10.2459\/JCM.0000000000001077.","journal-title":"J Cardiovasc Med Hagerstown Md"},{"issue":"1","key":"781_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/ATVBAHA.120.315291","volume":"41","author":"AP Patel","year":"2021","unstructured":"Patel AP, Wang M, Pirruccello JP, et al. Lp(a) (Lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national biobank. Arterioscler Thromb Vasc Biol. 2021;41(1):465\u201374. https:\/\/doi.org\/10.1161\/ATVBAHA.120.315291.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"781_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2015.08.021","volume":"242","author":"AH Nave","year":"2015","unstructured":"Nave AH, Lange KS, Leonards CO, et al. Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis. Atherosclerosis. 2015;242(2):496\u2013503. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.08.021.","journal-title":"Atherosclerosis"},{"issue":"22","key":"781_CR7","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1161\/CIRCULATIONAHA.120.045826","volume":"141","author":"SC Larsson","year":"2020","unstructured":"Larsson SC, Gill D, Mason AM, et al. Lipoprotein(a) in Alzheimer, atherosclerotic, cerebrovascular, thrombotic, and valvular disease: Mendelian randomization investigation. Circulation. 2020;141(22):1826\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.045826.","journal-title":"Circulation"},{"issue":"11","key":"781_CR8","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.jacc.2012.12.023","volume":"61","author":"PR Kamstrup","year":"2013","unstructured":"Kamstrup PR, Tybj\u00e6rg-Hansen A, Nordestgaard BG. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction. J Am Coll Cardiol. 2013;61(11):1146\u201356. https:\/\/doi.org\/10.1016\/j.jacc.2012.12.023.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"781_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111510","volume":"9","author":"G Brosolo","year":"2021","unstructured":"Brosolo G, Da Porto A, Bulfone L, et al. Plasma lipoprotein(a) levels as determinants of arterial stiffening in hypertension. Biomedicines. 2021;9(11):1510. https:\/\/doi.org\/10.3390\/biomedicines9111510.","journal-title":"Biomedicines"},{"issue":"5","key":"781_CR10","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3390\/jcm14051611","volume":"14","author":"SE van den Bosch","year":"2025","unstructured":"van den Bosch SE, de Boer LM, Revers A, et al. Association between lipoprotein(a) and arterial stiffness in young adults with familial hypercholesterolemia. J Clin Med. 2025;14(5):1611. https:\/\/doi.org\/10.3390\/jcm14051611.","journal-title":"J Clin Med"},{"issue":"5","key":"781_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14168","volume":"54","author":"A Simistiras","year":"2024","unstructured":"Simistiras A, Georgiopoulos G, Delialis D, Mavraganis G, Oikonomou E, Maneta E, et al. Association of lipoprotein(a) with arterial stiffness: a Mendelian randomization study. Eur J Clin Invest. 2024;54(5):e14168. https:\/\/doi.org\/10.1111\/eci.14168.","journal-title":"Eur J Clin Invest"},{"issue":"3-4","key":"781_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000517871","volume":"9","author":"K Papadopoulou-Legbelou","year":"2021","unstructured":"Papadopoulou-Legbelou K, Triantafyllou A, Vampertzi O, Koletsos N, Douma S, Papadopoulou-Alataki E. Similar myocardial perfusion and vascular stiffness in children and adolescents with high lipoprotein (a) levels, in comparison with healthy controls. Pulse. 2021;9(3\u20134):64\u201371. https:\/\/doi.org\/10.1159\/000517871.","journal-title":"Pulse"},{"key":"781_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2022.100107","volume":"77","author":"V Fran\u00e7a","year":"2022","unstructured":"Fran\u00e7a V, Gomes \u00c9IL, de Campos EVS, Zago VHdeS, Nunes VS, de Faria EC. Relationship between lipoprotein (a) and subclinical carotid atherosclerosis in asymptomatic individuals. Clinics. 2022;77:100107. https:\/\/doi.org\/10.1016\/j.clinsp.2022.100107.","journal-title":"Clinics"},{"issue":"6","key":"781_CR14","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1177\/1741826711423216","volume":"19","author":"P Calmarza","year":"2012","unstructured":"Calmarza P, Trejo JM, Lapresta C, Lopez P. Relationship between lipoprotein(a) concentrations and intima-media thickness: a healthy population study. Eur J Prev Cardiol. 2012;19(6):1290\u20135. https:\/\/doi.org\/10.1177\/1741826711423216.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"781_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2006.01.017","volume":"190","author":"MT Grebe","year":"2007","unstructured":"Grebe MT, Schoene E, Schaefer CA, et al. Elevated lipoprotein(a) does not promote early atherosclerotic changes of the carotid arteries in young, healthy adults. Atherosclerosis. 2007;190(1):194\u20138. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.01.017.","journal-title":"Atherosclerosis"},{"issue":"1","key":"781_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31728\/jnn.2024-00154","volume":"16","author":"M Sung","year":"2024","unstructured":"Sung M, Jung YH, Youn YH, Lee KY. Correlation between elevated lipoprotein(a) and carotid plaque in asymptomatic individuals. J Neurosonol Neuroimaging. 2024;16(1):1\u20137. https:\/\/doi.org\/10.31728\/jnn.2024-00154.","journal-title":"J Neurosonol Neuroimaging"},{"key":"781_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1260050","volume":"14","author":"X Yan","year":"2023","unstructured":"Yan X, Gong J, Wang Z, Wang F, Qi C. Association of lipoprotein(a) with left ventricular hypertrophy assessed by electrocardiogram in adults: a large cross-sectional study. Front Endocrinol. 2023;14:1260050. https:\/\/doi.org\/10.3389\/fendo.2023.1260050.","journal-title":"Front Endocrinol"},{"issue":"Suppl 2","key":"781_CR18","first-page":"S124","volume":"96","author":"R Krittayaphong","year":"2013","unstructured":"Krittayaphong R, Nomsawadi V, Muenkaew M, Miniphan M, Yindeengam A, Udompunturak S. Accuracy of ECG criteria for the diagnosis of left ventricular hypertrophy: a comparison with magnetic resonance imaging. J Med Assoc Thail Chotmaihet Thangphaet. 2013;96(Suppl 2):S124-132.","journal-title":"J Med Assoc Thail Chotmaihet Thangphaet."},{"issue":"1","key":"781_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24083","volume":"36","author":"B Wu","year":"2021","unstructured":"Wu B, Zhang Z, Long J, Zhao H, Zeng F. Association between lipoprotein (a) and heart failure with reduced ejection fraction development. J Clin Lab Anal. 2021;36(1):e24083. https:\/\/doi.org\/10.1002\/jcla.24083.","journal-title":"J Clin Lab Anal"},{"key":"781_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.747120","volume":"8","author":"Z Huang","year":"2021","unstructured":"Huang Z, Yang Y, Lu J, et al. Association of lipoprotein(a)-associated mortality and the estimated glomerular filtration rate level in patients undergoing coronary angiography: a 51,500 cohort study. Front Cardiovasc Med. 2021;8:747120. https:\/\/doi.org\/10.3389\/fcvm.2021.747120.","journal-title":"Front Cardiovasc Med"},{"issue":"19","key":"781_CR21","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1093\/eurheartj\/ehq165","volume":"31","author":"Reference Values for Arterial Stiffness\u2019 Collaboration","year":"2010","unstructured":"Reference Values for Arterial Stiffness\u2019 Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: \u201cestablishing normal and reference values.\u201d Eur Heart J. 2010;31(19):2338\u201350. https:\/\/doi.org\/10.1093\/eurheartj\/ehq165.","journal-title":"Eur Heart J"},{"issue":"4","key":"781_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/01.cir.55.4.613","volume":"55","author":"RB Devereux","year":"1977","unstructured":"Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55(4):613\u20138. https:\/\/doi.org\/10.1161\/01.cir.55.4.613.","journal-title":"Circulation"},{"issue":"5","key":"781_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jacl.2020.06.010","volume":"14","author":"EJ Brandt","year":"2020","unstructured":"Brandt EJ, Mani A, Spatz ES, Desai NR, Nasir K. Lipoprotein(a) levels and association with myocardial infarction and stroke in a nationally representative cross-sectional US cohort. J Clin Lipidol. 2020;14(5):695-706.e4. https:\/\/doi.org\/10.1016\/j.jacl.2020.06.010.","journal-title":"J Clin Lipidol"},{"issue":"1","key":"781_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016604","volume":"6","author":"L Dumitrescu","year":"2011","unstructured":"Dumitrescu L, Glenn K, Brown-Gentry K, et al. Variation in LPA is associated with Lp(a) levels in three populations from the Third National Health and Nutrition Examination Survey. PLoS ONE. 2011;6(1):e16604. https:\/\/doi.org\/10.1371\/journal.pone.0016604.","journal-title":"PLoS ONE"},{"issue":"5","key":"781_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.5603\/CJ.a2018.0106","volume":"26","author":"A Jubran","year":"2019","unstructured":"Jubran A, Zetser A, Zafrir B. Lipoprotein(a) screening in young and middle-aged patients presenting with acute coronary syndrome. Cardiol J. 2019;26(5):511\u20138. https:\/\/doi.org\/10.5603\/CJ.a2018.0106.","journal-title":"Cardiol J"},{"issue":"7","key":"781_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13117","volume":"49","author":"B Gencer","year":"2019","unstructured":"Gencer B, Rigamonti F, Nanchen D, et al. Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes. Eur J Clin Invest. 2019;49(7):e13117. https:\/\/doi.org\/10.1111\/eci.13117.","journal-title":"Eur J Clin Invest"},{"key":"781_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1362893","volume":"11","author":"G Wang","year":"2024","unstructured":"Wang G, Xia M, Liang C, Pu F, Liu S, Jia D. Prognostic value of elevated lipoprotein (a) in patients with acute coronary syndromes: a systematic review and meta-analysis. Front Cardiovasc Med. 2024;11:1362893. https:\/\/doi.org\/10.3389\/fcvm.2024.1362893.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"781_CR28","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.5114\/aoms\/188294","volume":"20","author":"K Dyrbu\u015b","year":"2024","unstructured":"Dyrbu\u015b K, M\u0119drala Z, Konsek K, et al. Lipoprotein(a) and its impact on cardiovascular disease - the Polish perspective: design and first results of the Zabrze-Lipoprotein(a) Registry. Arch Med Sci. 2024;20(4):1069\u201376. https:\/\/doi.org\/10.5114\/aoms\/188294.","journal-title":"Arch Med Sci"},{"key":"781_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2018.11.040","volume":"281","author":"A Vuorio","year":"2019","unstructured":"Vuorio A, Watts GF, Kovanen PT. Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia. Atherosclerosis. 2019;281:25\u201330. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.11.040.","journal-title":"Atherosclerosis"},{"issue":"10","key":"781_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jacasi.2024.08.008","volume":"4","author":"S Tsimikas","year":"2024","unstructured":"Tsimikas S. Lp(a) and accelerated progression of aortic stenosis: a rationale for universal measurement and therapeutic targeting. JACC Asia. 2024;4(10):761\u20133. https:\/\/doi.org\/10.1016\/j.jacasi.2024.08.008.","journal-title":"JACC Asia"},{"issue":"4","key":"781_CR31","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1002\/ehf2.13933","volume":"9","author":"Z Li","year":"2022","unstructured":"Li Z, Liu J, Shen J, et al. Association of lipoprotein (a) and 1\u00a0year prognosis in patients with heart failure with reduced ejection fraction. ESC Heart Fail. 2022;9(4):2399\u2013406. https:\/\/doi.org\/10.1002\/ehf2.13933.","journal-title":"ESC Heart Fail"},{"issue":"8","key":"781_CR32","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1161\/STROKEAHA.121.034924","volume":"53","author":"J Xu","year":"2022","unstructured":"Xu J, Hao X, Zhan R, et al. Effect of lipoprotein(a) on stroke recurrence attenuates at low LDL-C (low-density lipoprotein) and inflammation levels. Stroke. 2022;53(8):2504\u201311. https:\/\/doi.org\/10.1161\/STROKEAHA.121.034924.","journal-title":"Stroke"},{"issue":"13","key":"781_CR33","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","volume":"55","author":"C Vlachopoulos","year":"2010","unstructured":"Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318\u201327. https:\/\/doi.org\/10.1016\/j.jacc.2009.10.061.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"781_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01355-w","volume":"23","author":"Y Pei","year":"2023","unstructured":"Pei Y, Shu Y, Deng B, Liu Y. Association between brachial-ankle pulse wave velocity and microvascular complications in type 2 diabetes mellitus. BMC Endocr Disord. 2023;23(1):98. https:\/\/doi.org\/10.1186\/s12902-023-01355-w.","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"781_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s40292-015-0100-9","volume":"22","author":"A Maloberti","year":"2015","unstructured":"Maloberti A, Meani P, Varrenti M, et al. Structural and functional abnormalities of carotid artery and their relation with EVA phenomenon. High Blood Press Cardiovasc Prevent. 2015;22(4):373\u20139. https:\/\/doi.org\/10.1007\/s40292-015-0100-9.","journal-title":"High Blood Press Cardiovasc Prevent"},{"issue":"9","key":"781_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S2213-8587(23)00156-0","volume":"11","author":"LM de Boer","year":"2023","unstructured":"de Boer LM, Wiegman A, Kroon J, et al. Lipoprotein(a) and carotid intima-media thickness in children with familial hypercholesterolaemia in the Netherlands: a 20-year follow-up study. Lancet Diabetes Endocrinol. 2023;11(9):667\u201374. https:\/\/doi.org\/10.1016\/S2213-8587(23)00156-0.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"19","key":"781_CR37","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017020","volume":"9","author":"S Shimoda","year":"2020","unstructured":"Shimoda S, Kitamura A, Imano H, et al. Associations of carotid intima-media thickness and plaque heterogeneity with the risks of stroke subtypes and coronary artery disease in the Japanese general population: the circulatory risk in communities study. J Am Heart Assoc. 2020;9(19):e017020. https:\/\/doi.org\/10.1161\/JAHA.120.017020.","journal-title":"J Am Heart Assoc"},{"key":"781_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2022.04.013","volume":"349","author":"C Lamina","year":"2022","unstructured":"Lamina C. Mendelian randomization: principles and its usage in Lp(a) research. Atherosclerosis. 2022;349:36\u201341. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.04.013.","journal-title":"Atherosclerosis"},{"key":"781_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1260050","author":"X Yan","year":"2023","unstructured":"Yan X, Gong J, Wang Z, Wang F, Qi C. Association of lipoprotein(a) with left ventricular hypertrophy assessed by electrocardiogram in adults: a large cross-sectional study. Front Endocrinol. 2023. https:\/\/doi.org\/10.3389\/fendo.2023.1260050.","journal-title":"Front Endocrinol"},{"issue":"2","key":"781_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5935\/abc.20190120","volume":"113","author":"J Yan","year":"2019","unstructured":"Yan J, Pan Y, Xiao J, et al. High level of lipoprotein(a) as predictor for recurrent heart failure in patients with chronic heart failure: a cohort study. Arq Bras Cardiol. 2019;113(2):197\u2013204. https:\/\/doi.org\/10.5935\/abc.20190120.","journal-title":"Arq Bras Cardiol"},{"issue":"11","key":"781_CR41","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.038608","volume":"14","author":"S Nomura","year":"2025","unstructured":"Nomura S, Guan W, Zhang Y, et al. Lipoprotein(a) and heart failure among Black and White participants in Atherosclerosis Risk in Communities Study, Framingham Offspring Study, and Multi\u2010Ethnic Study of Atherosclerosis: the Pooling Project. J Am Heart Assoc. 2025;14(11):e038608. https:\/\/doi.org\/10.1161\/JAHA.124.038608.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"781_CR42","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1053\/ajkd.2002.36319","volume":"40","author":"CP Kovesdy","year":"2002","unstructured":"Kovesdy CP, Astor BC, Longenecker JC, Coresh J. Association of kidney function with serum lipoprotein(a) level: the third National Health and Nutrition Examination Survey (1991-1994). Am J Kidney Dis. 2002;40(5):899\u2013908. https:\/\/doi.org\/10.1053\/ajkd.2002.36319.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"781_CR43","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12882-023-03417-6","volume":"24","author":"H Zhang","year":"2023","unstructured":"Zhang H, Chen R, Xiang S, et al. Association between serum lipoprotein(a) and mildly reduced eGFR: a cross-sectional study. BMC Nephrol. 2023;24(1):364. https:\/\/doi.org\/10.1186\/s12882-023-03417-6.","journal-title":"BMC Nephrol"},{"issue":"3","key":"781_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae032","volume":"17","author":"G Zeng","year":"2024","unstructured":"Zeng G, Zhu P, Yuan D, et al. Renal function alters the association of lipoprotein(a) with cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a prospective cohort study. Clin Kidney J. 2024;17(3):sfae032. https:\/\/doi.org\/10.1093\/ckj\/sfae032.","journal-title":"Clin Kidney J"},{"issue":"1","key":"781_CR45","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","volume":"42","author":"G Reyes-Soffer","year":"2022","unstructured":"Reyes-Soffer G, Ginsberg HN, Berglund L, et al. Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American heart association. Arterioscler Thromb Vasc Biol. 2022;42(1):e48\u201360. https:\/\/doi.org\/10.1161\/ATV.0000000000000147.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3\u20134","key":"781_CR46","first-page":"143","volume":"57","author":"B Genser","year":"2011","unstructured":"Genser B, Dias KC, Siekmeier R, Stojakovic T, Grammer T, Maerz W. Lipoprotein (a) and risk of cardiovascular disease\u2013a systematic review and meta analysis of prospective studies. Clin Lab. 2011;57(3\u20134):143\u201356.","journal-title":"Clin Lab"},{"issue":"10","key":"781_CR47","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1161\/01.cir.102.10.1082","volume":"102","author":"J Danesh","year":"2000","unstructured":"Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation. 2000;102(10):1082\u20135. https:\/\/doi.org\/10.1161\/01.cir.102.10.1082.","journal-title":"Circulation"},{"key":"781_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejim.2016.08.018","volume":"37","author":"F Fogacci","year":"2017","unstructured":"Fogacci F, Cicero AF, D\u2019Addato S, et al. Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study. Eur J Intern Med. 2017;37:49\u201355. https:\/\/doi.org\/10.1016\/j.ejim.2016.08.018.","journal-title":"Eur J Intern Med"},{"issue":"6","key":"781_CR49","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jacc.2013.09.042","volume":"63","author":"M O\u2019Donoghue","year":"2014","unstructured":"O\u2019Donoghue M, Morrow DA, Tsimikas S, et al. Lipoprotein (a) for risk assessment in patients with established coronary artery disease. J Am Coll Cardiol. 2014;63(6):520\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2013.09.042.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"781_CR50","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jamacardio.2017.3833","volume":"3","author":"GG Schwartz","year":"2018","unstructured":"Schwartz GG, Ballantyne CM, Barter PJ, et al. Association of lipoprotein(a) with risk of recurrent ischemic events following acute coronary syndrome: analysis of the dal-outcomes randomized clinical trial. JAMA Cardiol. 2018;3(2):164\u20138. https:\/\/doi.org\/10.1001\/jamacardio.2017.3833.","journal-title":"JAMA Cardiol."},{"issue":"7","key":"781_CR51","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S2213-8587(17)30096-7","volume":"5","author":"S Zewinger","year":"2017","unstructured":"Zewinger S, Kleber ME, Tragante V, et al. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. Lancet Diabetes Endocrinol. 2017;5(7):534\u201343. https:\/\/doi.org\/10.1016\/S2213-8587(17)30096-7.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"781_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227054","volume":"15","author":"C Roth","year":"2020","unstructured":"Roth C, Krychtiuk KA, Gangl C, et al. Lipoprotein(a) plasma levels are not associated with survival after acute coronary syndromes: An observational cohort study. PLoS ONE. 2020;15(1):e0227054. https:\/\/doi.org\/10.1371\/journal.pone.0227054.","journal-title":"PLoS ONE"},{"issue":"1","key":"781_CR53","doi-asserted-by":"publisher","first-page":"2242501","DOI":"10.1080\/08037051.2023.2242501","volume":"32","author":"J Hu","year":"2023","unstructured":"Hu J, Zhou Y. Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: a meta-analysis of randomized trials. Blood Press. 2023;32(1):2242501. https:\/\/doi.org\/10.1080\/08037051.2023.2242501.","journal-title":"Blood Press"},{"issue":"8","key":"781_CR54","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jama.2022.13044","volume":"328","author":"CM Mangione","year":"2022","unstructured":"Mangione CM, Barry MJ, et al. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement. JAMA. 2022;328(8):746\u201353. https:\/\/doi.org\/10.1001\/jama.2022.13044.","journal-title":"JAMA"},{"issue":"10","key":"781_CR55","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1161\/STROKEAHA.120.031877","volume":"53","author":"H Zheng","year":"2022","unstructured":"Zheng H, Li H, Wang Y, et al. Rosuvastatin slows progression of carotid intima-media thickness: the METEOR-China randomized controlled study. Stroke. 2022;53(10):3004\u201313. https:\/\/doi.org\/10.1161\/STROKEAHA.120.031877.","journal-title":"Stroke"},{"key":"781_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5548310","volume":"2021","author":"M Alidadi","year":"2021","unstructured":"Alidadi M, Montecucco F, Jamialahmadi T, Al-Rasadi K, Johnston TP, Sahebkar A. Beneficial effect of statin therapy on arterial stiffness. BioMed Res Int. 2021;2021:5548310. https:\/\/doi.org\/10.1155\/2021\/5548310.","journal-title":"BioMed Res Int"},{"issue":"4","key":"781_CR57","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1194\/jlr.R061648","volume":"57","author":"SM Marcovina","year":"2016","unstructured":"Marcovina SM, Albers JJ. Lipoprotein (a) measurements for clinical application. J Lipid Res. 2016;57(4):526\u201337. https:\/\/doi.org\/10.1194\/jlr.R061648.","journal-title":"J Lipid Res"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-026-00781-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-026-00781-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-026-00781-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T16:11:03Z","timestamp":1781971863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-026-00781-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1007\/s40292-026-00781-w","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol complies with the Helsinki Declaration and was approved by the San Gerardo Hospital Ethics Committee and all participants provided informed written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}